Idera Pharma (IDRA) Misses Q4 EPS by 3c

Idera Pharma (NASDAQ: IDRA) reported Q4 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Idera Pharma (IDRA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'
• Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results